182 related articles for article (PubMed ID: 7699424)
1. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Bedenić B; Zagar Z
J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
[TBL] [Abstract][Full Text] [Related]
2. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Cooper CE; Slocombe B; White AR
J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
[TBL] [Abstract][Full Text] [Related]
3. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Bingen E; Bourgeois F; Chardon H; Doit C; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Doern GV; Tubert TA
Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
[TBL] [Abstract][Full Text] [Related]
5. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Laurans G; Gaudio F; Ducroix JP; Orfila J
Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Liljequist BO; Gezelius L
Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
[TBL] [Abstract][Full Text] [Related]
10. Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.
Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
Chemotherapy; 1988; 34(3):191-4. PubMed ID: 2843324
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.
Thorburn CE; Molesworth SJ; Sutherland R; Rittenhouse S
Antimicrob Agents Chemother; 1996 Dec; 40(12):2796-801. PubMed ID: 9124843
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
Doern GV
Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
Aguilar L; Martín M; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
[TBL] [Abstract][Full Text] [Related]
16. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
Cooper CE; Slocombe B; White AR
J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
[No Abstract] [Full Text] [Related]
17. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
18. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Texier-Maugein J; Escoubas J; Fouche J; Mormede M
Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
[TBL] [Abstract][Full Text] [Related]
19. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
Yeo SF; Livermore DM
J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
